Allison Klumpp
Physician Assistant · Roscommon, MINPI 1881160299
Payments from drug & device makers
Across 114 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$371
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$311
- Lilly USA, LLC$264
- AbbVie$236
- Boehringer Ingelheim$133
- Novo Nordisk$67
- plus $588 from 16 others
What the payments were for
- Food & beverage$1,970100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $371 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $311 |
| Lilly USA, LLC | 17 | $264 |
| AbbVie | 14 | $236 |
| Boehringer Ingelheim | 7 | $133 |
| Novo Nordisk | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Amgen | 3 | $54 |
| Merck | 4 | $53 |
| Pfizer | 3 | $52 |
| Johnson & Johnson | 3 | $43 |
| GSK | 3 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $36 |
| Novartis | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Bayer | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$148
How this compares
$1,970 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 142 | $178,071 |
| JardianceEmpagliflozin | 76 | $106,221 |
| OzempicSemaglutide | 53 | $66,518 |
| EliquisApixaban | 51 | $62,310 |
| RybelsusSemaglutide | 26 | $24,946 |
| XareltoRivaroxaban | 16 | $24,021 |
| FarxigaDapagliflozin Propanediol | 21 | $23,761 |
| TrulicityDulaglutide | 17 | $23,560 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $13,215 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,615 |
| VyvanseLisdexamfetamine Dimesylate | 20 | $7,776 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $6,543 |
| Humalog Kwikpen U-100Insulin Lispro | 20 | $5,982 |
| VascepaIcosapent Ethyl | 12 | $4,894 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $264 | $201,631159 claims |
| Boehringer IngelheimJardiance | $133 | $106,22176 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $67 | $94,90594 claims |
| PfizerEliquis | $52 | $62,31051 claims |
| AstraZenecaFarxiga, Symbicort | $371 | $28,03038 claims |
| Johnson & JohnsonXarelto | $43 | $24,02116 claims |
| GSKBreo Ellipta | $40 | $9,61515 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $62 | $7,77620 claims |
| Sanofi-aventis U.S. LLCLantus | $38 | $2,03411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Roscommon
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.